What is Ethris's industry?

Ethris's industry is Biotechnology

Who are Ethris's top competitors?

Ethris's top competitors are , , , , , ,

Ethris company information, Employees & Contact Information

Explore related pages

Ethris email format Ethris management contacts

Related company profiles:

Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, design and development of transcript therapies that restore missing functions in patients’ cells and tissues. We will advance transcript therapies to transform the treatment of disease independently and with our partners.

Employees: 47
Founded: -
Address: Semmelweisstr. 3, Planegg,82152,germany
Phone: 4908989557880
Email: in****@****ris.com
Industry: Biotechnology
Website: ethris.com
Keywords: Biotechnology, mRNA, LNPs, Vaccines, Therapeutics, Formulation, Manufacturing.
HQ: Planegg
Competitors: CureVac, Smart Reporting GmbH, deepc, ISAR Bioscience GmbH, Medigene AG, MorphoSys, Tubulis GmbH, iOmx Therapeutics AG, Immatics, Eisbach Bio GmbH.

Ethris Questions

News

CEPI partners with Ethris to increase access to RNA vaccines through spray-dry technique - CEPI

CEPI partners with Ethris to increase access to RNA vaccines through spray-dry technique CEPI

Evonik and Ethris Enter Strategic Partnership to Expand Offerings for Nucleic Acid Delivery - Yahoo Finance

Evonik and Ethris Enter Strategic Partnership to Expand Offerings for Nucleic Acid Delivery Yahoo Finance

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - Business Wire

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention Business Wire

Ethris Doses First Patient in Phase 2a Clinical Trial of Lead mRNA Candidate ETH47 for Asthma - Business Wire

Ethris Doses First Patient in Phase 2a Clinical Trial of Lead mRNA Candidate ETH47 for Asthma Business Wire

Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in mice - EMBO Press

Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in mice EMBO Press

Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms - Business Wire

Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms Business Wire

Ethris: ETH47ForPrevention Of Respiratory Viral Illnesses In Asthmatics Shows Promising Preliminary Phase 1 Results - 2 Minute Medicine

Ethris: ETH47ForPrevention Of Respiratory Viral Illnesses In Asthmatics Shows Promising Preliminary Phase 1 Results 2 Minute Medicine

Nasal mRNA therapy increases anti-viral cytokine in healthy people, candidate in asthma - Healio

Nasal mRNA therapy increases anti-viral cytokine in healthy people, candidate in asthma Healio

Ethris, Evonik Partner on Targeted mRNA Vaccines and Therapies - Contract Pharma

Ethris, Evonik Partner on Targeted mRNA Vaccines and Therapies Contract Pharma

Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology

Ethris and Lonza focus on mRNA respiratory condition vaccines Pharmaceutical Technology

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - Genetic Engineering and Biotechnology News

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention Genetic Engineering and Biotechnology News

Cipla EU to Invest EUR 15 million in Ethris, initiating a strategic collaboration - PR Newswire

Cipla EU to Invest EUR 15 million in Ethris, initiating a strategic collaboration PR Newswire

MHRA approves Ethris’ Phase I trial for inhaled mRNA drug - Clinical Trials Arena

MHRA approves Ethris’ Phase I trial for inhaled mRNA drug Clinical Trials Arena

Ethris Receives €10 Million EU4Health Grant to Support Clinical Development and Expand Antiviral Applications of Lead mRNA Candidate ETH47 - Business Wire

Ethris Receives €10 Million EU4Health Grant to Support Clinical Development and Expand Antiviral Applications of Lead mRNA Candidate ETH47 Business Wire

Ethris Joins Alliance for mRNA Medicines as a Founding Member - Yahoo Finance

Ethris Joins Alliance for mRNA Medicines as a Founding Member Yahoo Finance

Q&A: Inhaled mRNA therapy may help combat seasonal, emerging respiratory viruses - Healio

Q&A: Inhaled mRNA therapy may help combat seasonal, emerging respiratory viruses Healio

Ethris Announces $5 Million in Funding to Prepare Lead Candidate ETH47 for Phase 2 Study - Business Wire

Ethris Announces $5 Million in Funding to Prepare Lead Candidate ETH47 for Phase 2 Study Business Wire

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines - Contract Pharma

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines Contract Pharma

Ethris' inhaled mRNA-based asthma drug ups its target protein without toxicity, early data show - Fierce Biotech

Ethris' inhaled mRNA-based asthma drug ups its target protein without toxicity, early data show Fierce Biotech

Ethris Announces Positive Initial Phase 1 Data Demonstrating Nasal Delivery of mRNA Lead Candidate ETH47 - Lelezard

Ethris Announces Positive Initial Phase 1 Data Demonstrating Nasal Delivery of mRNA Lead Candidate ETH47 Lelezard

AstraZeneca inks respiratory disease mRNA pact with Ethris - Fierce Biotech

AstraZeneca inks respiratory disease mRNA pact with Ethris Fierce Biotech

Cipla to invest additional 3 mn euro in mRNA technology company Ethris - Business Standard

Cipla to invest additional 3 mn euro in mRNA technology company Ethris Business Standard

A Single Methylene Group in Oligoalkylamine-Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery - Wiley Online Library

A Single Methylene Group in Oligoalkylamine-Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery Wiley Online Library

Cipla EU to invest € 15 million in Ethris - Indian Pharma Post

Cipla EU to invest € 15 million in Ethris Indian Pharma Post

Companies like Ethris

Top Ethris Employees

Olga Mykhailyk

Principal Research Scientist At Ethris Gmbh / Retired

Greater Munich Metropolitan Area, Germany, Germany

View

2
lrz.tu-muenchen.de, ethris.com
Dr. Christian Wawrzinek

Managing Director At Ethris & Ceo At Laureus Capital

N/a

View
Justin Duckworth

n/a

United Kingdom, United Kingdom

View

1
gmail.com
Thomas W. Chalberg, PhD

Entrepreneur, Executive, Investor

N/a

View

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ethris company information, Employees & Contact Information

Explore related pages

Company Details

Ethris Questions

What is Ethris's helpline number?

What is Ethris's official website?

What is Ethris's LinkedIn profile?

How many employees are working in Ethris right now?

What is Ethris's industry?

What are Ethris's top competitors?

What is Ethris's support email address?

What are Ethris's categories?

When was Ethris founded?

News

CEPI partners with Ethris to increase access to RNA vaccines through spray-dry technique - CEPI

Evonik and Ethris Enter Strategic Partnership to Expand Offerings for Nucleic Acid Delivery - Yahoo Finance

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - Business Wire

Ethris Doses First Patient in Phase 2a Clinical Trial of Lead mRNA Candidate ETH47 for Asthma - Business Wire

Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in mice - EMBO Press

Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms - Business Wire

Ethris: ETH47ForPrevention Of Respiratory Viral Illnesses In Asthmatics Shows Promising Preliminary Phase 1 Results - 2 Minute Medicine

Nasal mRNA therapy increases anti-viral cytokine in healthy people, candidate in asthma - Healio

Ethris, Evonik Partner on Targeted mRNA Vaccines and Therapies - Contract Pharma

Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - Genetic Engineering and Biotechnology News

Cipla EU to Invest EUR 15 million in Ethris, initiating a strategic collaboration - PR Newswire

MHRA approves Ethris’ Phase I trial for inhaled mRNA drug - Clinical Trials Arena

Ethris Receives €10 Million EU4Health Grant to Support Clinical Development and Expand Antiviral Applications of Lead mRNA Candidate ETH47 - Business Wire

Ethris Joins Alliance for mRNA Medicines as a Founding Member - Yahoo Finance

Q&A: Inhaled mRNA therapy may help combat seasonal, emerging respiratory viruses - Healio

Ethris Announces $5 Million in Funding to Prepare Lead Candidate ETH47 for Phase 2 Study - Business Wire

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines - Contract Pharma

Ethris' inhaled mRNA-based asthma drug ups its target protein without toxicity, early data show - Fierce Biotech

Ethris Announces Positive Initial Phase 1 Data Demonstrating Nasal Delivery of mRNA Lead Candidate ETH47 - Lelezard

AstraZeneca inks respiratory disease mRNA pact with Ethris - Fierce Biotech

Cipla to invest additional 3 mn euro in mRNA technology company Ethris - Business Standard

A Single Methylene Group in Oligoalkylamine-Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery - Wiley Online Library

Cipla EU to invest € 15 million in Ethris - Indian Pharma Post

Companies like Ethris

Iomx Therapeutics Ag

Eisbach Bio Gmbh

Smart Reporting Gmbh

Medigene Ag

Morphosys

Tubulis Gmbh

Curevac

Isar Bioscience Gmbh

Immatics

Deepc

Top Ethris Employees

Olga Mykhailyk

Principal Research Scientist At Ethris Gmbh / Retired

Dr. Christian Wawrzinek

Managing Director At Ethris & Ceo At Laureus Capital

Justin Duckworth

n/a

Thomas W. Chalberg, PhD

Entrepreneur, Executive, Investor

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data